Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Oncimmune Holdings Plc LSE:ONC London Ordinary Share GB00BYQ94H38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  10.00 5.97% 177.50 175.00 180.00 177.50 167.50 169.50 50,531 14:34:59
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.2 -8.5 -13.0 - 123

Oncimmune Share Discussion Threads

Showing 126 to 148 of 150 messages
Chat Pages: 6  5  4  3  2  1
DateSubjectAuthorDiscuss
16/10/2020
11:59
And a few more at 168 and change
volsung
13/10/2020
07:32
Bought me some of these here shares
volsung
08/10/2020
08:54
Indeed and a decent move again today.
waterloo01
08/10/2020
08:53
Indeed, I'm happy with that...
chester
08/10/2020
08:45
Such a quiet board here considering the move we have had this year
arab3
31/7/2020
07:55
Regarding false negatives, that is very true pugugly. One thing I do definitely recognize is that it is likely to be a much better test than PSA which is as much use as a chocolate tea pot. If I had held since 40p Waterloo, I definitely wouldn't be a seller now, not even to fund a replacement for a dear and recently departed steed
timbo003
31/7/2020
07:25
Unfortunately the trusty steed (Yamaha 550 Virago) has given up the ghost. I miss it and will replace at some time. I invested here at 40p ish but agree re specificity, having said that it's a bit of a numbers game and it's a relatively cheap test to run and will still pick up many early that otherwise wouldn't even have the old finger test. Pugugly, CT guided biopsy is a lot more accurate these days, but still not not 100% and is an invasive, unpleasant and expensive.
waterloo01
31/7/2020
07:23
timbo003 - but far better than a false negative - Even a multi-needle biopsy often misses - like trying to hit a pip in an orange with half a dozen needles-
pugugly
31/7/2020
07:16
I remember it well Waterloo and your revelation that you got around London on a motorbike (but cannot remember which one), something I would never do with either of my two iron steeds. With Oncimmune, I follow with interest, but haven't invested, I'm still not entirely convinced the specificity is up to it (hence my question in the Q&As). The last thing you need is a false positive on something like a prostate test, which then lead to an unnecessary and extremely invasive prostate exam 😨
timbo003
31/7/2020
07:02
Cheers. Didn't know you were also into ONC. We met once Timbo at an IMM AGM. I was the one asking most of the questions.
waterloo01
31/7/2020
06:59
They gave investors a heads up on this news at last night's Proactiveinvestor presentation, there were a couple of good Q&As at the end 😉 https://youtu.be/KGfO_FEasaQ?t=4219
timbo003
31/7/2020
06:45
All going rather well Dr Adam M Hill, CEO of Oncimmune, said: "We are delighted to see the ECLS trial data published in the European Respiratory Journal, as it both expands the availability of these results in the wider pulmonology community and confirms through peer review the findings and clinical potential of EarlyCDT Lung. The ECLS trial data was presented on the Presidents podium at WCLC 2019 in Barcelona last year. This publication will unlock discussions with a number of health systems on implementation, many of whom have been looking forward to the validation that this much anticipated peer review brings. We and our partners will now work at speed with health authorities in the UK and further afield to roll out EarlyCDT Lung more widely, ahead of a fuller analysis of the survival benefit of EarlyCDT Lung."
waterloo01
09/7/2020
20:30
Simply, most people have have not heard of Oncimmune, but I am pretty sure the next 6-9 months will change that!
shearluc
09/7/2020
20:11
I can't understand why this isn't on the move given the good news recently, seems to be well under the radar and not traded much??
recut more
07/7/2020
17:59
htTps://www.thisismoney.co.uk/money/markets/article-8494479/Oncimmune-highlights-resurgence-Britains-biotech-sector.html
waterloo01
11/6/2020
07:15
Here, @DDS_DocHoliday recently caught up with @OncimmuneECDT CEO Dr. Adam Hill. #ONC profiles the body's immune response to detect evidence of the body's natural response to cancer.In a fascinating interview Hill explains a little more...https://total-market-solutions.com/2020/06/11/oncimmune-plc/
burtond1
05/6/2020
06:49
Decent number of director buys.
waterloo01
28/5/2020
08:24
Oncimmune Holdings PLC said Thursday that it has signed a new contract with Swiss pharmaceutical giant Roche Holding AG to profile autoantibodies in patient samples collected during cancer immunotherapy trials. The U.K. immunodiagnostics group said the contract, for the use of Oncimmune's SeroTag biomarker discovery platform to explore autoantibody profiles in patients that received cancer immunotherapy, will start immediately. Initial results are scheduled to be provided to Roche within three months, with project completion by November, Oncimmune said. Oncimmune Chief Executive Adam M Hill said this is the largest contract the company has signed to date and builds upon the collaborative work between the two companies in recent months. Write to Adria Calatayud at adria.calatayud@dowjones.com (END) Dow Jones Newswires May 28, 2020 03:04 ET (07:04 GMT)
adrian j boris
21/5/2020
07:42
Re foothill - On reflection a possibly more plain English interpretation should be a "toehold contract"!!
pugugly
21/5/2020
07:30
"Foothill Contract" - Suggest early stage? Negotiations? The fact that it's signed is reassuring....would that stop another big pharma making enquiries?
shearluc
21/5/2020
06:51
lol. Agreed never seen it sued but understand the intention.
waterloo01
21/5/2020
06:34
What the hell is a "foothil contract" https://www.investegate.co.uk/oncimmune-hldngs-plc--onc-/rns/earlycdt-lung-partnership-contract-signed/202005210700115417N/ New one on me - never come across before - Neither it appears has Google!!
pugugly
14/5/2020
11:40
Can't find this could you explain please
pinkie
Chat Pages: 6  5  4  3  2  1
ADVFN Advertorial
Your Recent History
LSE
ONC
Oncimmune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201030 02:14:37